Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project.

MLA

Rizzo, Alessandro, et al. “Pembrolizumab in Patients with Advanced Upper Tract Urothelial Carcinoma: A Real-World Study from ARON-2 Project.” Clinical & Experimental Metastasis, vol. 41, no. 5, Oct. 2024, pp. 655–65. EBSCOhost, https://doi.org/10.1007/s10585-024-10296-0.

APA

Rizzo, A., Buti, S., Giannatempo, P., Salah, S., Molina-Cerrillo, J., Massari, F., Kopp, R. M., Fiala, O., Galli, L., Myint, Z. W., Tural, D., Soares, A., Pichler, R., Mennitto, A., Abahssain, H., Calabrò, F., Monteiro, F. S. M., Albano, A., Mollica, V., … Santoni, M. (2024). Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project. Clinical & Experimental Metastasis, 41(5), 655–665. https://doi.org/10.1007/s10585-024-10296-0

Chicago

Rizzo, Alessandro, Sebastiano Buti, Patrizia Giannatempo, Samer Salah, Javier Molina-Cerrillo, Francesco Massari, Ray Manneh Kopp, et al. 2024. “Pembrolizumab in Patients with Advanced Upper Tract Urothelial Carcinoma: A Real-World Study from ARON-2 Project.” Clinical & Experimental Metastasis 41 (5): 655–65. doi:10.1007/s10585-024-10296-0.